SlideShare a Scribd company logo
CLINICAL
PHARMACY IN
RHEUMATOLOGY
RHEUMATIC DISEASES
 Rheumatic diseases (rheumatism) are painful
conditions that affect millions. These diseases
cause inflammation, swelling, and pain in the
joints or muscles.
 Some rheumatic diseases like osteoarthritis are
the result of "wear and tear" to the joints. Other
rheumatic diseases, such as rheumatoid arthritis
, happen when the immune system goes
haywire; the immune system attacks the linings
of joints, causing joint pain, swelling, and
destruction.
 Rheumatism is a medical term once frequently used to
describe disorders associated with many different parts of
the body. Most often, people associate rheumatism with
arthritis, or with rheumatic fever, a complication of
strep throat that can result in damage to the heart.
However, the term rheumatism might apply to the
symptoms of numerous conditions that can cause pain
and/or weakness.
 Some conditions that were once given the general label of
rheumatism or called rheumatic diseases include,
rheumatoid arthritis, osteoarthritis, lupus, fibromyalgia, and
tendonitis. Frequently autoimmune disorders, since they
remained unnamed but caused pain as well as affecting
other organs, were classed as rheumatism. Illnesses like
lupus were particularly susceptible to being called
rheumatism. Later understanding of the actions of these
illnesses show that the problem is not dysfunction of the
joints, but rather immune systems that can attack joints,
muscles and organs.
Some forms of rheumatism are called non-
articular rheumatism and may affect the soft
tissues causing pain throughout the body.
Conditions like tendonitis and fibromyalgia fall
into this category. As well, non-articular
rheumatism can be localized to specific areas
in the body. Bursitis is a non-articular form of
rheumatism that affects and inflames the bursa
, which are special sacs that protect joints and
overlapping muscles. Bursitis most frequently
occurs at the site of one joint that may have
been injured through overuse.
Sponsored
Medical Lecture Notes – All Subjects
USMLE Exam (America) – Practice
Fibromyalgia
OsteoarthritisOA is not a normal part of aging; it usually affects the
knees, hips, lower back, neck, and fingers.
 The signs and symptoms of OA include:
 Pain in joint
 Joint swelling
 Joint may be warm to touch
 Joint stiffness
 Muscle weakness and joint instability
 Pain when walking
 Difficulty gripping objects
 Difficulty dressing or combing hair
 Difficulty sitting or bending over 
To diagnose OA, doctor will ask the patient about medical
history and symptoms and do a physical exam. Blood
tests may help rule out other types of arthritis or medical
problems. A joint fluid sample from an affected joint may
also be examined to eliminate other medical problems.
Osteoarthritis
Rheumatoid Arthritis
RA is sometimes called a crippling disease. That's because it
can result in permanent joint damage and
deformity.
 
RA signs and symptoms include:
 Joint pain, stiffness, and swelling
 Involvement of multiple joints (symmetrical pattern)
 Other organ involvement
 Joint stiffness, especially in the morning
 Fatigue
 Fevers
 Lumps called rheumatoid
nodules
To diagnose RA, doctor will ask about medical history and do
a physical examination. Also, X-rays and blood tests will
likely be taken. One blood test may be for
rheumatoid factor; it is positive in 70% to 80% of those with
RA.
Rheumatoid Arthritis
LupusSLE or systemic lupus erythematosus is another autoimmune disease;
the cause of SLE is unknown.
Lupus signs and symptoms include:
 Joint pain
 Fatigue
 Joint stiffness
 Rashes, including the"butterfly rash" across the cheeks
 Sun sensitivity
 Hair loss
 Discoloration of the fingers or toes when exposed to cold (called
Raynaud's phenomenon)
 Internal organ involvement, such as the kidneys
 Blood disorders, such as anemia and blood clots
 Chest pain from inflammation of the lining of the heart or lungs
 Seizures or strokes
To diagnose lupus, doctor will ask about medical history, do a physical
exam, and order lab tests of blood and urine samples. One blood
test is the antinuclear antibody test (ANA). Most people with lupus
have a positive ANA blood test.
Systemic lupus erythematosus
Ankylosing SpondylitisAnkylosing Spondylitis (AS) usually starts gradually as lower back
pain. The hallmark feature of AS is the involvement of the joints at
the base of the spine. This is where the spine attaches to the
pelvis, also known as the sacroiliac joints.
Ankylosing spondylitis is more common in young men, especially
from the teenage years to age 30.
AS symptoms include:
 Gradual pain in the lower back and buttocks
 Lower back pain that worsens and works its way up the spine
 Pain felt between the shoulder blades and in the neck
 Pain and stiffness in the back, especially at rest and on arising
 Pain and stiffness get better after activity
 Pain in the middle back and then upper back and neck (after 5-10
years)
With progression of AS, the spine may become stiffer. It may become
difficult to bend for common everyday activities.
To diagnose AS, doctor will ask about medical history and perform a
physical exam. X-rays of the back looking at the sacroiliac joints
may help in making an AS diagnosis. A positive blood test for
HLA-B27 protein may help confirm a diagnosis.
Ankylosing Spondylitis
Sjogren's Syndrome
Sjogren's syndrome is an inflammatory, autoimmune disease. It can
occur with other autoimmune diseases such as RA and lupus, but
also on its own. Although the cause of Sjogren's is unknown, it is
more common in
women.
Sjogren's signs and symptoms include:
 Dry eyes (the glands in eyes do not give adequate tears)
 Eye irritation and burning
 Dry mouth (the glands in mouth do not give adequate saliva)
 Dental decay, gum disease, thrush
 Swelling of the parotid glands on the sides of the face
 Joint pain and stiffness (rarely)
 Internal organ diseases (rarely)
To diagnose Sjogren's syndrome, doctor will do a physical exam and
ask about medical history. Blood tests and other tests may also be
performed. A simple biopsy of the inner lip or other area may help
confirm the diagnosis.
Sjogren's Syndrome
Venus Williams Diagnosed With
Sjogren’s Syndrome
Drugs used to treat arthritis:
 Painkillers (analgesics) - These reduce pain. They are
used for many different types of arthritis and are often
used together with other drugs.
 Non-steroidal anti-inflammatory drugs (NSAIDs)
- These reduce inflammation of the joint as well as
pain. They are used for many different types of arthritis,
often along with other drugs.
 Disease-modifying anti-rheumatic drugs (DMARDs)
- This group of drugs is used mainly in the treatment of
rheumatoid arthritis but also in some other rheumatic
diseases. They reduce pain, swelling and stiffness.
 Corticosteroids (steroids) - These drugs are very
effective in controlling inflammation.
NSAIDs can be very effective against inflammation, but they do not prevent
tissue damage. Even when NSAIDs are controlling the inflammation, the
joint or organ damage of arthritis can continue to get worse. NSAIDs only
lessen pain and discomfort. They do not affect underlying disease.
Non steroidal anti-inflammatory drugs (NSAIDs) are examples of drugs that
act on enzymes. NSAIDs inhibits the enzyme cyclo-oxygenase (COX) which
catalyses a reaction in the biochemical pathway that results in the production
of prostaglandins, important mediators in the inflammatory response.
NSAIDs. Mechanism(s) of Action
The more an NSAID blocks COX-1, the greater is its
tendency to cause ulcers and promote bleeding. One
NSAID, celecoxib (Celebrex), blocks COX-2 but has little
effect on COX-1, and is therefore further classified as a
selective COX-2 inhibitor. Selective COX-2 inhibitors
cause less bleeding and fewer ulcers than other
NSAIDs.
NSAIDs can be classified based on their chemical
structure or mechanism of action. Older NSAIDs were
known long before their mechanism of action was
elucidated and were for this reason classified by
chemical structure or origin. Newer substances are
more often classified by mechanism of action.
Salicylates
 Aspirin (acetylsalicylic acid)
 Diflunisal
 Salsalate
NSAIDs
Propionic acid derivatives
 Ibuprofen
 Naproxen
 Fenoprofen
 Ketoprofen
 Flurbiprofen
 Oxaprozin
Acetic acid derivatives
 Indomethacin
 Sulindac
 Etodolac
 Ketorolac
 Diclofenac (Safety alert by FDA)
 Nabumetone
NSAIDs
Enolic acid (Oxicam) derivatives
 Piroxicam
 Meloxicam
 Tenoxicam
 Droxicam
 Lornoxicam
 Isoxicam
Fenamic acid derivatives( Fenamates )
 Mefenamic acid
 Meclofenamic acid
 Flufenamic acid
 Tolfenamic acid
NSAIDs
Selective COX-2 inhibitors (Coxibs)
 Celecoxib (FDA alert)
 Rofecoxib (withdrawn from market)
 Valdecoxib (withdrawn from market)
 Parecoxib FDA withdrawn
 Lumiracoxib TGA cancelled registration
 Etoricoxib FDA withdrawn
 Firocoxib used in dogs and horses
Sulphonanilides
 Nimesulide (systemic preparations are banned by several
countries for the potential risk of hepatotoxicity)
Others
 Licofelone acts by inhibiting LOX (lipooxygenase) & COX
and hence known as 5-LOX/COX inhibitor
NSAIDs are generally indicated for the
symptomatic relief of the following conditions:
 Rheumatoid arthritis
 Osteoarthritis
 Inflammatory arthropathies (e.g. ankylosing spondylitis,
psoriatic arthritis, Reiter's syndrome)
 Acute gout
 Dysmenorrhoea (menstrual pain)
 Metastatic bone pain
 Headache and migraine
 Postoperative pain
 Mild-to-moderate pain due to inflammation and tissue injury
 Pyrexia (fever)
 Ileus
 Renal colic
 They are also given to neonate infants whose ductus arteriosus is
not closed within 24 hours of birth
 Aspirin, the only NSAID able to irreversibly inhibit COX-1, is also
indicated for inhibition of platelet aggregation.
Complications of NSAIDs
NSAIDs are safe drugs. However, they have many side effects. The
side effects happen more often when they are used over long periods
of time, which is common in arthritis patients. Some of the side effects
can become very serious. GI Effects
NSAIDs irritate the gastrointestinal (GI) tract (the digestive system--your
esophagus, stomach, and intestines). They increase the production of
gastric acid, and they harm the gastric lining. NSAIDs aggravate ulcers
and GI bleeding. Up to 5 percent of people who use NSAIDs for a year
develop ulcers, bleeding, or tears in the GI tract. The risks are higher
for older patients, patients with a history of GI problems, and patients
with heart disease.
 Blood Effects
NSAIDs make it harder for the platelets in your blood to clump together at
the site of an injury. This can cause bleeding problems. Aspirin
especially has this effect. Before you have surgery, you should stop
taking aspirin for two weeks to prevent bleeding problems.
 Liver Effects
NSAIDs can be toxic to your liver. You will not feel this, but elevated
levels of certain liver enzymes can easily be seen in blood tests. Liver
function almost always returns to normal when you stop taking
NSAIDs.
 Kidney Effects
NSAIDs can make it hard for your kidneys to get rid of
some kinds of wastes. If you have a history of kidney
problems, or if your disease may affect your kidneys,
your doctor will use NSAIDs with caution.
 Other Effects
Some people get skin reactions and rashes from NSAIDs.
Some get a combination of runny nose, polyps in the
nose, and asthma. Different kinds of NSAIDs can have
different side effects. Salicylates can cause problems
with hearing. Other kinds of NSAIDs can cause
headaches and confusion, especially in elderly patients.
Many of the possible side effects depend on your health
and the disease for which you are being treated.
Individuals can react very differently to the same NSAIDs.
You and your doctor must work together to find the type
and dose of NSAID that controls your symptoms without
causing unwanted side effects.
CORTICOSTEROIDS
Corticosteroids may regulate gene expression in several ways.
Corticosteroids enter the cell to bind to GR in the cytoplasm that
translocate to the nucleus. GR homodimers bind to GRE in the
promoter region of steroid-sensitive genes, which may encode
anti-inflammatory proteins. Less commonly, GR homodimers
interact with negative GREs to suppress genes, particularly those
linked to side effects of corticosteroids. Nuclear GR also interact
with coactivator molecules, such as CBP, which is activated by
proinflammatory transcription factors, such as NF- B, thus
switching off the inflammatory genes that are activated by these
transcription factors. Other abbreviations: SLPI: secretory
leukoprotease inhibitor; MKP-1: mitogen-activated kinase
phosphatase-1; I B- : inhibitor of NF- B; GILZ: glucocorticoid-
induced leucine zipper protein; POMC: proopiomelanocortin;
CRF: corticotrophin-releasing factor.
CORTICOSTEROIDS
Uses of Corticosteroids
 Corticosteroids are chemical copies of hormones that
occur naturally in your body. The most commonly used
corticosteroids are prednisone, prednisolone, and
methylprednisolone. Corticosteroids can be given orally or
put directly into the bloodstream through an intravenous
needle. They can also be injected directly into an inflamed
spot. Corticosteroid cream can be rubbed on the skin.
 Corticosteroids are powerful drugs. They drastically
decrease inflammation. But they are also highly toxic.
Doctors have different opinions about how corticosteroids
should be used.
 Corticosteroids can't cure your disease. But they do seem
to affect the development of some diseases, including
rheumatoid arthritis (RA).
CORTICOSTEROIDS
Complications of Corticosteroids
Corticosteroids can have many unwanted effects on your body. Whether or not
you develop these complications depends on many factors: what type of
corticosteroid you take, your dose, the length of time you are on it, and how
sensitive your body is to these hormones. The most common side effects
are.
 Osteoporosis
 All corticosteroids slow bone growth and create conditions that lead to
osteoporosis, a disease process that results in reduction of bone mass.
Compression fractures of the vertebrae can happen with long-term
corticosteroid use. Men and women past menopause are most likely to
develop osteoporosis. Your doctor may recommend that you take calcium
and vitamin D pills while you take corticosteroids.
 Infections
 High levels of corticosteroids hinder your body's ability to fight bacterial
infections. High-dose corticosteroids can even mask the symptoms of some
types of infections, such as abscesses and bowel tears. Most viral infections
are not a problem, except for herpes.
 Adrenal Insufficiency
 This means that your pituitary and adrenal glands can't produce enough of
certain kinds of hormones. This can happen after taking corticosteroids in
moderate doses for only a few days. Adrenal insufficiency is most likely to
happen as you are reducing the dosage. It can be a problem if you need
surgery or if you get an infection or serious injury.
Withdrawal
 When stop taking corticosteroids, the doses will be slowly reduced
over a period of days or weeks. Even if patient has only been taking
steroids for a few weeks, he will still need to taper off. Corticosteroid
withdrawal can be very difficult for body. In many patients, the
disease symptoms become worse. Some people experience a
sickness that includes fevers, nausea, vomiting, low blood pressure,
and low blood sugar. Others have withdrawal symptoms that include
muscle and joint pain, weight loss, fever, and headaches. If patient
have problems coming off corticosteroids, doctor will have taper off
the drug more slowly.
 Different people, and different diseases, react very differently to
corticosteroids.
Contraindications to Use
Corticosteroids are contraindicated in
systemic fungal infections and in people who are
hypersensitive to drug formulations. They should be
used with caution in clients at risk for infections (they
may decrease resistance), clients with infections (they
may mask signs and symptoms so that infections
become more severe before they are recognized and
treated), diabetes mellitus (they cause or increase
hyperglycemia), peptic ulcer disease, inflammatory
bowel disorders, hypertension, congestive heart failure,
and renal insufficiency.
Disease-modifying Anti-rheumatic
Drugs (DMARDs)
 The early use of disease-modifying anti-rheumatic drugs
(DMARDs) has been recommended in recent years to
reduce disease progression and long-term disability.The
need for early use of DMARDs is incorporated in new
National Institute for Health and Clinical Excellence
(NICE) guidance. Early use requires early referral in part
because DMARD initiation is the province of specialists in
secondary care. The optimum use of these drugs requires
specialist experience and is complicated not only
because of their potential toxicity, but also by the range
and combination of drugs used. There are a number of
new DMARDs.
DMARDs
 The prevailing guidelines for the management of rheumatoid
arthritis (RA) recommend that, once the disease has been
diagnosed and its impact on the patient's life documented,
DMARDs should be commenced. DMARDs should be part of a
range of treatments from different professional disciplines. For
further details see separate article Management of Rheumatoid
Arthritis.
 DMARDs either affect the immune response or suppress the
disease process. As well as improving the symptoms and signs
of the arthritis, they may also improve the extra-articular
manifestations such as vasculitis in addition to exerting systemic
effects.
Any DMARD that has been prescribed should be recorded in a
patient's notes, both written and electronic, so that all doctors
prescribing for that patient will be aware of any potential
interactions with other drugs.
Types of disease-modifying anti-
rheumatic drugs
DRUGS WHICH SUPPRESS THE DISEASE
PROCESS
Gold:
 May be given either orally as auranofin or by intramuscular
injection as sodium aurothiomalate.
 Sodium aurothiomalate is licensed for the treatment of
rheumatoid arthritis (RA) and juvenile idiopathic arthritis.
 Can be an effective treatment but use is restricted by severe
adverse reactions (up to 5% of recipients).
 Sodium aurothiomalate has a greater toxicity than auranofin,
but tends to be more effective and has a faster onset of
action.
 Either drug should be withdrawn if no benefit is seen after six
months.
Types of disease-modifying anti-rheumatic drugs
DRUGS WHICH SUPPRESS THE DISEASE PROCESS
Penicillamine
 It is a chelating agent licensed for the treatment of severe
active rheumatoid arthritis, including juvenile forms (and a
range of other conditions, including Wilson's disease).
 It has a similar method of action to gold and more patients
are able to tolerate it, but side-effects occur frequently.
 The rate of onset of action is slow, improvement may not be
seen for three months but, in patients who have shown no
benefit after a year of treatment, the drug should be
discontinued.
Sulfasalazine
 It is licensed for the treatment of RA which has failed to
respond to non-steroidal anti-inflammatory drugs (NSAIDs).
 It has a similar action to gold.
 It has slightly more side-effects than methotrexate.
Types of disease-modifying anti-
rheumatic drugs
Drugs which affect the immune process
Chloroquine and hydroxychloroquine
 Hydroxychloroquine is an antimalarial agent licensed for the
treatment of RA, juvenile idiopathic arthritis, discoid and
systemic lupus erythematosus, and dermatological conditions
caused, or aggravated, by sunlight.
 They are usually better tolerated than gold or penicillamine.
Methotrexate
 May be used in the treatment of RA and psoriatic arthritis.
 It is a disease-modifying agent with both anti-inflammatory and
immunosuppressant activity.
 It is also classified as an antimetabolite cytotoxic agent, and is
the most common first-line agent for the early treatment of RA in
the UK.
Types of disease-modifying anti-
rheumatic drugs
Drugs which affect the immune process
Azathioprine
 It is a cytotoxic drug and a prodrug of mercaptopurine.
 It is used as an immunosuppressant for many autoimmune conditions and to
suppress transplant rejection.
 It acts in a similar manner to methotrexate but is usually reserved as second-
line due to its toxicity.
Ciclosporin
 It is a powerful immunosuppressant that appears to act specifically on
lymphocytes (mainly helper T cells) resulting in depression of the cell-
mediated immune response.
 Unlike cytotoxic immunosuppressants (such as cyclophosphamide) it has
little effect on bone marrow.
 It is licensed for the treatment of severe active rheumatoid arthritis when the
usual second-line therapy is inappropriate or ineffective.
Leflunomide
 Leflunomide has antiproliferative properties.
 It is licensed for the treatment of adults with active RA and also for active
psoriatic arthritis.
 It is used in the treatment of moderate-to-severe, active RA, often in
combination with methotrexate.
Antitumour necrosis factor or
biological agents
The term biological agents
encompasses tumour necrosis factor
(TNF)-alpha blockers (infliximab,
etanercept, and adalimumab) and other
agents, including abatacept, anakinra,
and rituximab.
Choosing the right DMARD
Current evidence suggests that combinations of
DMARDs are more effective, and probably less toxic,
than monotherapy.Methotrexate is often used as an
anchor drug, combined with hydroxychloroquine,
sulfasalazine or leflunomide. An anti-TNF-alpha drug
such as etanercept or infliximab may also be used in
combination. There is a stronger evidence base for the
disease-modifying effects of methotrexate,
sulfasalazine, leflunomide and intramuscular gold than
for hydroxychloroquine, penicillamine, oral gold,
ciclosporin or azathioprine, although these agents do
improve symptoms and some objective measures of
inflammation. The choice of first agent or combination
of agents should be based on a risk/benefit analysis for
individual patients.
Monitoring
The use of disease-modifying anti-rheumatic
drugs (DMARDs) is limited by potentially serious
side-effects, and therefore patients who are
taking these drugs should be monitored on a
regular basis as in the table below. Note
throughout that, whilst absolute values are
useful indicators, trends are also important.
Hence any rapid fall or consistent downward
trend in any parameter warrants extra vigilance.

More Related Content

What's hot

rheumatoid arthritis
rheumatoid arthritisrheumatoid arthritis
rheumatoid arthritis
Ashwini Somayaji
 
Rheumatoid arthritis ppt by ann..
Rheumatoid arthritis ppt by ann..Rheumatoid arthritis ppt by ann..
Rheumatoid arthritis ppt by ann..
Anjali Rarichan
 
Pathophysiology of Rheumatoid Arthritis
Pathophysiology of  Rheumatoid ArthritisPathophysiology of  Rheumatoid Arthritis
Pathophysiology of Rheumatoid Arthritis
Nem kumar Jain
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Viraj Shinde
 
Rheumatoid Arthritis
Rheumatoid Arthritis Rheumatoid Arthritis
Rheumatoid Arthritis
Sreeja Saladi
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
keerthi samuel
 
Drug induced pulmonary diseases
Drug induced pulmonary diseasesDrug induced pulmonary diseases
Drug induced pulmonary diseases
AsfiyaSam
 
Pathophysiology of Gout
Pathophysiology of GoutPathophysiology of Gout
Pathophysiology of Gout
BAVAMH
 
Ten Principles in Osteoarthritis Management
Ten Principles in Osteoarthritis ManagementTen Principles in Osteoarthritis Management
Ten Principles in Osteoarthritis Management
Rachmat Gunadi Wachjudi
 
Rheumatoid arthritis and management
Rheumatoid arthritis and managementRheumatoid arthritis and management
Rheumatoid arthritis and management
Harsh shaH
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Nuthan DeSouza
 
Pharmacotherapy of Chronic Obstructive Pulmonary Disease
Pharmacotherapy of Chronic Obstructive Pulmonary DiseasePharmacotherapy of Chronic Obstructive Pulmonary Disease
Pharmacotherapy of Chronic Obstructive Pulmonary Disease
Tsegaye Melaku
 
Osteoporosis - Pharmacotherapy
Osteoporosis - Pharmacotherapy Osteoporosis - Pharmacotherapy
Osteoporosis - Pharmacotherapy
Areej Abu Hanieh
 
Drug Induced Pulmonary Diseases
Drug Induced Pulmonary DiseasesDrug Induced Pulmonary Diseases
Drug Induced Pulmonary Diseases
Health Forager
 
lupus presentation final
lupus presentation finallupus presentation final
Pathophysiology of rheumatoid arthritis
Pathophysiology of rheumatoid arthritisPathophysiology of rheumatoid arthritis
Pathophysiology of rheumatoid arthritis
Tajuddin Shaik
 
Hepatitis (jaundice)
Hepatitis (jaundice)Hepatitis (jaundice)
Hepatitis (jaundice)
Lazoi Lifecare Private Limited
 
HEALTH SCREENING SERVICES
HEALTH SCREENING SERVICESHEALTH SCREENING SERVICES
HEALTH SCREENING SERVICES
Ramesh Ganpisetti
 
Rheumatoid arthitis
Rheumatoid arthitis Rheumatoid arthitis
Rheumatoid arthitis
SUDHEER BABU
 
Gout
GoutGout

What's hot (20)

rheumatoid arthritis
rheumatoid arthritisrheumatoid arthritis
rheumatoid arthritis
 
Rheumatoid arthritis ppt by ann..
Rheumatoid arthritis ppt by ann..Rheumatoid arthritis ppt by ann..
Rheumatoid arthritis ppt by ann..
 
Pathophysiology of Rheumatoid Arthritis
Pathophysiology of  Rheumatoid ArthritisPathophysiology of  Rheumatoid Arthritis
Pathophysiology of Rheumatoid Arthritis
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Rheumatoid Arthritis
Rheumatoid Arthritis Rheumatoid Arthritis
Rheumatoid Arthritis
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Drug induced pulmonary diseases
Drug induced pulmonary diseasesDrug induced pulmonary diseases
Drug induced pulmonary diseases
 
Pathophysiology of Gout
Pathophysiology of GoutPathophysiology of Gout
Pathophysiology of Gout
 
Ten Principles in Osteoarthritis Management
Ten Principles in Osteoarthritis ManagementTen Principles in Osteoarthritis Management
Ten Principles in Osteoarthritis Management
 
Rheumatoid arthritis and management
Rheumatoid arthritis and managementRheumatoid arthritis and management
Rheumatoid arthritis and management
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Pharmacotherapy of Chronic Obstructive Pulmonary Disease
Pharmacotherapy of Chronic Obstructive Pulmonary DiseasePharmacotherapy of Chronic Obstructive Pulmonary Disease
Pharmacotherapy of Chronic Obstructive Pulmonary Disease
 
Osteoporosis - Pharmacotherapy
Osteoporosis - Pharmacotherapy Osteoporosis - Pharmacotherapy
Osteoporosis - Pharmacotherapy
 
Drug Induced Pulmonary Diseases
Drug Induced Pulmonary DiseasesDrug Induced Pulmonary Diseases
Drug Induced Pulmonary Diseases
 
lupus presentation final
lupus presentation finallupus presentation final
lupus presentation final
 
Pathophysiology of rheumatoid arthritis
Pathophysiology of rheumatoid arthritisPathophysiology of rheumatoid arthritis
Pathophysiology of rheumatoid arthritis
 
Hepatitis (jaundice)
Hepatitis (jaundice)Hepatitis (jaundice)
Hepatitis (jaundice)
 
HEALTH SCREENING SERVICES
HEALTH SCREENING SERVICESHEALTH SCREENING SERVICES
HEALTH SCREENING SERVICES
 
Rheumatoid arthitis
Rheumatoid arthitis Rheumatoid arthitis
Rheumatoid arthitis
 
Gout
GoutGout
Gout
 

Similar to Clinical pharmacy in Rheumatology

Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Sijo A
 
Presentation1
Presentation1Presentation1
presentation on arthritis
presentation on arthritispresentation on arthritis
presentation on arthritis
NighatKanwal
 
Rhematoid arthritis
Rhematoid arthritisRhematoid arthritis
Rhematoid arthritis
Sumanah Nasiry
 
Rheumatoid Arthritis
Rheumatoid ArthritisRheumatoid Arthritis
Rheumatoid Arthritis
DhieMhie
 
Rheumatiod arthritis ppt
Rheumatiod arthritis pptRheumatiod arthritis ppt
Rheumatiod arthritis ppt
raj shekar
 
Arthritis
ArthritisArthritis
Arthritis
Paudel Sushil
 
FINAL ARTHRITIS (1).pptx
FINAL ARTHRITIS (1).pptxFINAL ARTHRITIS (1).pptx
FINAL ARTHRITIS (1).pptx
SonamDubey36
 
Psoriatic Arthritis: A Common Culprit Behind Joint Discomfort By Dr. Conway ...
Psoriatic Arthritis: A Common Culprit Behind Joint Discomfort  By Dr. Conway ...Psoriatic Arthritis: A Common Culprit Behind Joint Discomfort  By Dr. Conway ...
Psoriatic Arthritis: A Common Culprit Behind Joint Discomfort By Dr. Conway ...
Khalid Chamakh
 
Arthritis (wajaulmafasil)
Arthritis (wajaulmafasil)Arthritis (wajaulmafasil)
Arthritis (wajaulmafasil)
dilshad ali
 
Psoriatic arthritis
Psoriatic arthritisPsoriatic arthritis
Psoriatic arthritis
hamidreza227
 
What is rheumatoid arthritis
What is rheumatoid arthritisWhat is rheumatoid arthritis
What is rheumatoid arthritis
Santosh Gyawali
 
Arthritis Reference.pdf
Arthritis  Reference.pdfArthritis  Reference.pdf
Arthritis Reference.pdf
ShanthilallRamsunkar
 
Arthritis
ArthritisArthritis
Arthritis
sonals58
 
rheumatic_diseases (2).ppt
rheumatic_diseases (2).pptrheumatic_diseases (2).ppt
rheumatic_diseases (2).ppt
EetaJain1
 
Arthrits...
Arthrits...  Arthrits...
Arthrits...
SUMBUL AWAN
 
psoriaticarthritis-160303125216.pdf
psoriaticarthritis-160303125216.pdfpsoriaticarthritis-160303125216.pdf
psoriaticarthritis-160303125216.pdf
LahariNaidu7
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
sgpharshida
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Hite$H Patel
 
Rheumatic diseases
Rheumatic diseasesRheumatic diseases
Rheumatic diseases
Amer
 

Similar to Clinical pharmacy in Rheumatology (20)

Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Presentation1
Presentation1Presentation1
Presentation1
 
presentation on arthritis
presentation on arthritispresentation on arthritis
presentation on arthritis
 
Rhematoid arthritis
Rhematoid arthritisRhematoid arthritis
Rhematoid arthritis
 
Rheumatoid Arthritis
Rheumatoid ArthritisRheumatoid Arthritis
Rheumatoid Arthritis
 
Rheumatiod arthritis ppt
Rheumatiod arthritis pptRheumatiod arthritis ppt
Rheumatiod arthritis ppt
 
Arthritis
ArthritisArthritis
Arthritis
 
FINAL ARTHRITIS (1).pptx
FINAL ARTHRITIS (1).pptxFINAL ARTHRITIS (1).pptx
FINAL ARTHRITIS (1).pptx
 
Psoriatic Arthritis: A Common Culprit Behind Joint Discomfort By Dr. Conway ...
Psoriatic Arthritis: A Common Culprit Behind Joint Discomfort  By Dr. Conway ...Psoriatic Arthritis: A Common Culprit Behind Joint Discomfort  By Dr. Conway ...
Psoriatic Arthritis: A Common Culprit Behind Joint Discomfort By Dr. Conway ...
 
Arthritis (wajaulmafasil)
Arthritis (wajaulmafasil)Arthritis (wajaulmafasil)
Arthritis (wajaulmafasil)
 
Psoriatic arthritis
Psoriatic arthritisPsoriatic arthritis
Psoriatic arthritis
 
What is rheumatoid arthritis
What is rheumatoid arthritisWhat is rheumatoid arthritis
What is rheumatoid arthritis
 
Arthritis Reference.pdf
Arthritis  Reference.pdfArthritis  Reference.pdf
Arthritis Reference.pdf
 
Arthritis
ArthritisArthritis
Arthritis
 
rheumatic_diseases (2).ppt
rheumatic_diseases (2).pptrheumatic_diseases (2).ppt
rheumatic_diseases (2).ppt
 
Arthrits...
Arthrits...  Arthrits...
Arthrits...
 
psoriaticarthritis-160303125216.pdf
psoriaticarthritis-160303125216.pdfpsoriaticarthritis-160303125216.pdf
psoriaticarthritis-160303125216.pdf
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Rheumatic diseases
Rheumatic diseasesRheumatic diseases
Rheumatic diseases
 

More from Eneutron

PGCET Textile 2018 question paper
PGCET Textile 2018 question paperPGCET Textile 2018 question paper
PGCET Textile 2018 question paper
Eneutron
 
PGCET Polymer science 2018 question paper
PGCET Polymer science 2018 question paperPGCET Polymer science 2018 question paper
PGCET Polymer science 2018 question paper
Eneutron
 
PGCET Mechanical 2018 question paper
PGCET Mechanical 2018 question paperPGCET Mechanical 2018 question paper
PGCET Mechanical 2018 question paper
Eneutron
 
PGCET Environmental 2018 question paper
PGCET Environmental 2018 question paperPGCET Environmental 2018 question paper
PGCET Environmental 2018 question paper
Eneutron
 
PGCET Electrical sciences 2018 question paper
PGCET Electrical sciences 2018 question paperPGCET Electrical sciences 2018 question paper
PGCET Electrical sciences 2018 question paper
Eneutron
 
PGCET Computer science 2018 question paper
PGCET Computer science 2018 question paperPGCET Computer science 2018 question paper
PGCET Computer science 2018 question paper
Eneutron
 
PGCET Civil 2018 question paper
PGCET Civil 2018 question paperPGCET Civil 2018 question paper
PGCET Civil 2018 question paper
Eneutron
 
PGCET Chemical 2018 question paper
PGCET Chemical 2018 question paperPGCET Chemical 2018 question paper
PGCET Chemical 2018 question paper
Eneutron
 
PGCET Biotechnology 2018 question paper
PGCET Biotechnology 2018 question paperPGCET Biotechnology 2018 question paper
PGCET Biotechnology 2018 question paper
Eneutron
 
Pgcet Architecture 2018 question paper
Pgcet Architecture 2018 question paperPgcet Architecture 2018 question paper
Pgcet Architecture 2018 question paper
Eneutron
 
Pgcet Architecture 2017 question paper
Pgcet Architecture 2017 question paperPgcet Architecture 2017 question paper
Pgcet Architecture 2017 question paper
Eneutron
 
PGCET MBA 2018 question paper
PGCET MBA 2018 question paperPGCET MBA 2018 question paper
PGCET MBA 2018 question paper
Eneutron
 
Civil Service 2019 Prelims Previous Question Paper - 2
Civil Service 2019 Prelims Previous Question Paper - 2Civil Service 2019 Prelims Previous Question Paper - 2
Civil Service 2019 Prelims Previous Question Paper - 2
Eneutron
 
Civil Service 2019 Prelims Previous Question Paper - 1
Civil Service 2019 Prelims Previous Question Paper - 1Civil Service 2019 Prelims Previous Question Paper - 1
Civil Service 2019 Prelims Previous Question Paper - 1
Eneutron
 
Civil Service 2018 Prelims Previous Question Paper - 2
Civil Service 2018 Prelims Previous Question Paper - 2Civil Service 2018 Prelims Previous Question Paper - 2
Civil Service 2018 Prelims Previous Question Paper - 2
Eneutron
 
Civil Service 2018 Prelims Previous Question Paper - 1
Civil Service 2018 Prelims Previous Question Paper - 1Civil Service 2018 Prelims Previous Question Paper - 1
Civil Service 2018 Prelims Previous Question Paper - 1
Eneutron
 
Civil Service 2017 Prelims Previous Question Paper - 2
Civil Service 2017 Prelims Previous Question Paper - 2Civil Service 2017 Prelims Previous Question Paper - 2
Civil Service 2017 Prelims Previous Question Paper - 2
Eneutron
 
Civil Service 2017 Prelims Previous Question Paper - 1
Civil Service 2017 Prelims Previous Question Paper - 1Civil Service 2017 Prelims Previous Question Paper - 1
Civil Service 2017 Prelims Previous Question Paper - 1
Eneutron
 
SNAP 2013 Answer Key
SNAP 2013 Answer KeySNAP 2013 Answer Key
SNAP 2013 Answer Key
Eneutron
 
SNAP 2014 Answer Key
SNAP 2014 Answer KeySNAP 2014 Answer Key
SNAP 2014 Answer Key
Eneutron
 

More from Eneutron (20)

PGCET Textile 2018 question paper
PGCET Textile 2018 question paperPGCET Textile 2018 question paper
PGCET Textile 2018 question paper
 
PGCET Polymer science 2018 question paper
PGCET Polymer science 2018 question paperPGCET Polymer science 2018 question paper
PGCET Polymer science 2018 question paper
 
PGCET Mechanical 2018 question paper
PGCET Mechanical 2018 question paperPGCET Mechanical 2018 question paper
PGCET Mechanical 2018 question paper
 
PGCET Environmental 2018 question paper
PGCET Environmental 2018 question paperPGCET Environmental 2018 question paper
PGCET Environmental 2018 question paper
 
PGCET Electrical sciences 2018 question paper
PGCET Electrical sciences 2018 question paperPGCET Electrical sciences 2018 question paper
PGCET Electrical sciences 2018 question paper
 
PGCET Computer science 2018 question paper
PGCET Computer science 2018 question paperPGCET Computer science 2018 question paper
PGCET Computer science 2018 question paper
 
PGCET Civil 2018 question paper
PGCET Civil 2018 question paperPGCET Civil 2018 question paper
PGCET Civil 2018 question paper
 
PGCET Chemical 2018 question paper
PGCET Chemical 2018 question paperPGCET Chemical 2018 question paper
PGCET Chemical 2018 question paper
 
PGCET Biotechnology 2018 question paper
PGCET Biotechnology 2018 question paperPGCET Biotechnology 2018 question paper
PGCET Biotechnology 2018 question paper
 
Pgcet Architecture 2018 question paper
Pgcet Architecture 2018 question paperPgcet Architecture 2018 question paper
Pgcet Architecture 2018 question paper
 
Pgcet Architecture 2017 question paper
Pgcet Architecture 2017 question paperPgcet Architecture 2017 question paper
Pgcet Architecture 2017 question paper
 
PGCET MBA 2018 question paper
PGCET MBA 2018 question paperPGCET MBA 2018 question paper
PGCET MBA 2018 question paper
 
Civil Service 2019 Prelims Previous Question Paper - 2
Civil Service 2019 Prelims Previous Question Paper - 2Civil Service 2019 Prelims Previous Question Paper - 2
Civil Service 2019 Prelims Previous Question Paper - 2
 
Civil Service 2019 Prelims Previous Question Paper - 1
Civil Service 2019 Prelims Previous Question Paper - 1Civil Service 2019 Prelims Previous Question Paper - 1
Civil Service 2019 Prelims Previous Question Paper - 1
 
Civil Service 2018 Prelims Previous Question Paper - 2
Civil Service 2018 Prelims Previous Question Paper - 2Civil Service 2018 Prelims Previous Question Paper - 2
Civil Service 2018 Prelims Previous Question Paper - 2
 
Civil Service 2018 Prelims Previous Question Paper - 1
Civil Service 2018 Prelims Previous Question Paper - 1Civil Service 2018 Prelims Previous Question Paper - 1
Civil Service 2018 Prelims Previous Question Paper - 1
 
Civil Service 2017 Prelims Previous Question Paper - 2
Civil Service 2017 Prelims Previous Question Paper - 2Civil Service 2017 Prelims Previous Question Paper - 2
Civil Service 2017 Prelims Previous Question Paper - 2
 
Civil Service 2017 Prelims Previous Question Paper - 1
Civil Service 2017 Prelims Previous Question Paper - 1Civil Service 2017 Prelims Previous Question Paper - 1
Civil Service 2017 Prelims Previous Question Paper - 1
 
SNAP 2013 Answer Key
SNAP 2013 Answer KeySNAP 2013 Answer Key
SNAP 2013 Answer Key
 
SNAP 2014 Answer Key
SNAP 2014 Answer KeySNAP 2014 Answer Key
SNAP 2014 Answer Key
 

Recently uploaded

The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
Gokuldas Hospital
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
DIVYANSHU740006
 

Recently uploaded (20)

The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
 

Clinical pharmacy in Rheumatology

  • 2. RHEUMATIC DISEASES  Rheumatic diseases (rheumatism) are painful conditions that affect millions. These diseases cause inflammation, swelling, and pain in the joints or muscles.  Some rheumatic diseases like osteoarthritis are the result of "wear and tear" to the joints. Other rheumatic diseases, such as rheumatoid arthritis , happen when the immune system goes haywire; the immune system attacks the linings of joints, causing joint pain, swelling, and destruction.
  • 3.  Rheumatism is a medical term once frequently used to describe disorders associated with many different parts of the body. Most often, people associate rheumatism with arthritis, or with rheumatic fever, a complication of strep throat that can result in damage to the heart. However, the term rheumatism might apply to the symptoms of numerous conditions that can cause pain and/or weakness.  Some conditions that were once given the general label of rheumatism or called rheumatic diseases include, rheumatoid arthritis, osteoarthritis, lupus, fibromyalgia, and tendonitis. Frequently autoimmune disorders, since they remained unnamed but caused pain as well as affecting other organs, were classed as rheumatism. Illnesses like lupus were particularly susceptible to being called rheumatism. Later understanding of the actions of these illnesses show that the problem is not dysfunction of the joints, but rather immune systems that can attack joints, muscles and organs.
  • 4. Some forms of rheumatism are called non- articular rheumatism and may affect the soft tissues causing pain throughout the body. Conditions like tendonitis and fibromyalgia fall into this category. As well, non-articular rheumatism can be localized to specific areas in the body. Bursitis is a non-articular form of rheumatism that affects and inflames the bursa , which are special sacs that protect joints and overlapping muscles. Bursitis most frequently occurs at the site of one joint that may have been injured through overuse.
  • 5. Sponsored Medical Lecture Notes – All Subjects USMLE Exam (America) – Practice
  • 7. OsteoarthritisOA is not a normal part of aging; it usually affects the knees, hips, lower back, neck, and fingers.  The signs and symptoms of OA include:  Pain in joint  Joint swelling  Joint may be warm to touch  Joint stiffness  Muscle weakness and joint instability  Pain when walking  Difficulty gripping objects  Difficulty dressing or combing hair  Difficulty sitting or bending over  To diagnose OA, doctor will ask the patient about medical history and symptoms and do a physical exam. Blood tests may help rule out other types of arthritis or medical problems. A joint fluid sample from an affected joint may also be examined to eliminate other medical problems.
  • 9. Rheumatoid Arthritis RA is sometimes called a crippling disease. That's because it can result in permanent joint damage and deformity.   RA signs and symptoms include:  Joint pain, stiffness, and swelling  Involvement of multiple joints (symmetrical pattern)  Other organ involvement  Joint stiffness, especially in the morning  Fatigue  Fevers  Lumps called rheumatoid nodules To diagnose RA, doctor will ask about medical history and do a physical examination. Also, X-rays and blood tests will likely be taken. One blood test may be for rheumatoid factor; it is positive in 70% to 80% of those with RA.
  • 10.
  • 12. LupusSLE or systemic lupus erythematosus is another autoimmune disease; the cause of SLE is unknown. Lupus signs and symptoms include:  Joint pain  Fatigue  Joint stiffness  Rashes, including the"butterfly rash" across the cheeks  Sun sensitivity  Hair loss  Discoloration of the fingers or toes when exposed to cold (called Raynaud's phenomenon)  Internal organ involvement, such as the kidneys  Blood disorders, such as anemia and blood clots  Chest pain from inflammation of the lining of the heart or lungs  Seizures or strokes To diagnose lupus, doctor will ask about medical history, do a physical exam, and order lab tests of blood and urine samples. One blood test is the antinuclear antibody test (ANA). Most people with lupus have a positive ANA blood test.
  • 14. Ankylosing SpondylitisAnkylosing Spondylitis (AS) usually starts gradually as lower back pain. The hallmark feature of AS is the involvement of the joints at the base of the spine. This is where the spine attaches to the pelvis, also known as the sacroiliac joints. Ankylosing spondylitis is more common in young men, especially from the teenage years to age 30. AS symptoms include:  Gradual pain in the lower back and buttocks  Lower back pain that worsens and works its way up the spine  Pain felt between the shoulder blades and in the neck  Pain and stiffness in the back, especially at rest and on arising  Pain and stiffness get better after activity  Pain in the middle back and then upper back and neck (after 5-10 years) With progression of AS, the spine may become stiffer. It may become difficult to bend for common everyday activities. To diagnose AS, doctor will ask about medical history and perform a physical exam. X-rays of the back looking at the sacroiliac joints may help in making an AS diagnosis. A positive blood test for HLA-B27 protein may help confirm a diagnosis.
  • 16.
  • 17. Sjogren's Syndrome Sjogren's syndrome is an inflammatory, autoimmune disease. It can occur with other autoimmune diseases such as RA and lupus, but also on its own. Although the cause of Sjogren's is unknown, it is more common in women. Sjogren's signs and symptoms include:  Dry eyes (the glands in eyes do not give adequate tears)  Eye irritation and burning  Dry mouth (the glands in mouth do not give adequate saliva)  Dental decay, gum disease, thrush  Swelling of the parotid glands on the sides of the face  Joint pain and stiffness (rarely)  Internal organ diseases (rarely) To diagnose Sjogren's syndrome, doctor will do a physical exam and ask about medical history. Blood tests and other tests may also be performed. A simple biopsy of the inner lip or other area may help confirm the diagnosis.
  • 18. Sjogren's Syndrome Venus Williams Diagnosed With Sjogren’s Syndrome
  • 19.
  • 20. Drugs used to treat arthritis:  Painkillers (analgesics) - These reduce pain. They are used for many different types of arthritis and are often used together with other drugs.  Non-steroidal anti-inflammatory drugs (NSAIDs) - These reduce inflammation of the joint as well as pain. They are used for many different types of arthritis, often along with other drugs.  Disease-modifying anti-rheumatic drugs (DMARDs) - This group of drugs is used mainly in the treatment of rheumatoid arthritis but also in some other rheumatic diseases. They reduce pain, swelling and stiffness.  Corticosteroids (steroids) - These drugs are very effective in controlling inflammation.
  • 21.
  • 22. NSAIDs can be very effective against inflammation, but they do not prevent tissue damage. Even when NSAIDs are controlling the inflammation, the joint or organ damage of arthritis can continue to get worse. NSAIDs only lessen pain and discomfort. They do not affect underlying disease.
  • 23. Non steroidal anti-inflammatory drugs (NSAIDs) are examples of drugs that act on enzymes. NSAIDs inhibits the enzyme cyclo-oxygenase (COX) which catalyses a reaction in the biochemical pathway that results in the production of prostaglandins, important mediators in the inflammatory response.
  • 25.
  • 26.
  • 27. The more an NSAID blocks COX-1, the greater is its tendency to cause ulcers and promote bleeding. One NSAID, celecoxib (Celebrex), blocks COX-2 but has little effect on COX-1, and is therefore further classified as a selective COX-2 inhibitor. Selective COX-2 inhibitors cause less bleeding and fewer ulcers than other NSAIDs.
  • 28.
  • 29.
  • 30. NSAIDs can be classified based on their chemical structure or mechanism of action. Older NSAIDs were known long before their mechanism of action was elucidated and were for this reason classified by chemical structure or origin. Newer substances are more often classified by mechanism of action. Salicylates  Aspirin (acetylsalicylic acid)  Diflunisal  Salsalate
  • 31. NSAIDs Propionic acid derivatives  Ibuprofen  Naproxen  Fenoprofen  Ketoprofen  Flurbiprofen  Oxaprozin Acetic acid derivatives  Indomethacin  Sulindac  Etodolac  Ketorolac  Diclofenac (Safety alert by FDA)  Nabumetone
  • 32. NSAIDs Enolic acid (Oxicam) derivatives  Piroxicam  Meloxicam  Tenoxicam  Droxicam  Lornoxicam  Isoxicam Fenamic acid derivatives( Fenamates )  Mefenamic acid  Meclofenamic acid  Flufenamic acid  Tolfenamic acid
  • 33. NSAIDs Selective COX-2 inhibitors (Coxibs)  Celecoxib (FDA alert)  Rofecoxib (withdrawn from market)  Valdecoxib (withdrawn from market)  Parecoxib FDA withdrawn  Lumiracoxib TGA cancelled registration  Etoricoxib FDA withdrawn  Firocoxib used in dogs and horses Sulphonanilides  Nimesulide (systemic preparations are banned by several countries for the potential risk of hepatotoxicity) Others  Licofelone acts by inhibiting LOX (lipooxygenase) & COX and hence known as 5-LOX/COX inhibitor
  • 34. NSAIDs are generally indicated for the symptomatic relief of the following conditions:  Rheumatoid arthritis  Osteoarthritis  Inflammatory arthropathies (e.g. ankylosing spondylitis, psoriatic arthritis, Reiter's syndrome)  Acute gout  Dysmenorrhoea (menstrual pain)  Metastatic bone pain  Headache and migraine  Postoperative pain  Mild-to-moderate pain due to inflammation and tissue injury  Pyrexia (fever)  Ileus  Renal colic  They are also given to neonate infants whose ductus arteriosus is not closed within 24 hours of birth  Aspirin, the only NSAID able to irreversibly inhibit COX-1, is also indicated for inhibition of platelet aggregation.
  • 35. Complications of NSAIDs NSAIDs are safe drugs. However, they have many side effects. The side effects happen more often when they are used over long periods of time, which is common in arthritis patients. Some of the side effects can become very serious. GI Effects NSAIDs irritate the gastrointestinal (GI) tract (the digestive system--your esophagus, stomach, and intestines). They increase the production of gastric acid, and they harm the gastric lining. NSAIDs aggravate ulcers and GI bleeding. Up to 5 percent of people who use NSAIDs for a year develop ulcers, bleeding, or tears in the GI tract. The risks are higher for older patients, patients with a history of GI problems, and patients with heart disease.  Blood Effects NSAIDs make it harder for the platelets in your blood to clump together at the site of an injury. This can cause bleeding problems. Aspirin especially has this effect. Before you have surgery, you should stop taking aspirin for two weeks to prevent bleeding problems.  Liver Effects NSAIDs can be toxic to your liver. You will not feel this, but elevated levels of certain liver enzymes can easily be seen in blood tests. Liver function almost always returns to normal when you stop taking NSAIDs.
  • 36.  Kidney Effects NSAIDs can make it hard for your kidneys to get rid of some kinds of wastes. If you have a history of kidney problems, or if your disease may affect your kidneys, your doctor will use NSAIDs with caution.  Other Effects Some people get skin reactions and rashes from NSAIDs. Some get a combination of runny nose, polyps in the nose, and asthma. Different kinds of NSAIDs can have different side effects. Salicylates can cause problems with hearing. Other kinds of NSAIDs can cause headaches and confusion, especially in elderly patients. Many of the possible side effects depend on your health and the disease for which you are being treated. Individuals can react very differently to the same NSAIDs. You and your doctor must work together to find the type and dose of NSAID that controls your symptoms without causing unwanted side effects.
  • 37. CORTICOSTEROIDS Corticosteroids may regulate gene expression in several ways. Corticosteroids enter the cell to bind to GR in the cytoplasm that translocate to the nucleus. GR homodimers bind to GRE in the promoter region of steroid-sensitive genes, which may encode anti-inflammatory proteins. Less commonly, GR homodimers interact with negative GREs to suppress genes, particularly those linked to side effects of corticosteroids. Nuclear GR also interact with coactivator molecules, such as CBP, which is activated by proinflammatory transcription factors, such as NF- B, thus switching off the inflammatory genes that are activated by these transcription factors. Other abbreviations: SLPI: secretory leukoprotease inhibitor; MKP-1: mitogen-activated kinase phosphatase-1; I B- : inhibitor of NF- B; GILZ: glucocorticoid- induced leucine zipper protein; POMC: proopiomelanocortin; CRF: corticotrophin-releasing factor.
  • 38.
  • 39.
  • 41. Uses of Corticosteroids  Corticosteroids are chemical copies of hormones that occur naturally in your body. The most commonly used corticosteroids are prednisone, prednisolone, and methylprednisolone. Corticosteroids can be given orally or put directly into the bloodstream through an intravenous needle. They can also be injected directly into an inflamed spot. Corticosteroid cream can be rubbed on the skin.  Corticosteroids are powerful drugs. They drastically decrease inflammation. But they are also highly toxic. Doctors have different opinions about how corticosteroids should be used.  Corticosteroids can't cure your disease. But they do seem to affect the development of some diseases, including rheumatoid arthritis (RA).
  • 43. Complications of Corticosteroids Corticosteroids can have many unwanted effects on your body. Whether or not you develop these complications depends on many factors: what type of corticosteroid you take, your dose, the length of time you are on it, and how sensitive your body is to these hormones. The most common side effects are.  Osteoporosis  All corticosteroids slow bone growth and create conditions that lead to osteoporosis, a disease process that results in reduction of bone mass. Compression fractures of the vertebrae can happen with long-term corticosteroid use. Men and women past menopause are most likely to develop osteoporosis. Your doctor may recommend that you take calcium and vitamin D pills while you take corticosteroids.  Infections  High levels of corticosteroids hinder your body's ability to fight bacterial infections. High-dose corticosteroids can even mask the symptoms of some types of infections, such as abscesses and bowel tears. Most viral infections are not a problem, except for herpes.  Adrenal Insufficiency  This means that your pituitary and adrenal glands can't produce enough of certain kinds of hormones. This can happen after taking corticosteroids in moderate doses for only a few days. Adrenal insufficiency is most likely to happen as you are reducing the dosage. It can be a problem if you need surgery or if you get an infection or serious injury.
  • 44.
  • 45. Withdrawal  When stop taking corticosteroids, the doses will be slowly reduced over a period of days or weeks. Even if patient has only been taking steroids for a few weeks, he will still need to taper off. Corticosteroid withdrawal can be very difficult for body. In many patients, the disease symptoms become worse. Some people experience a sickness that includes fevers, nausea, vomiting, low blood pressure, and low blood sugar. Others have withdrawal symptoms that include muscle and joint pain, weight loss, fever, and headaches. If patient have problems coming off corticosteroids, doctor will have taper off the drug more slowly.  Different people, and different diseases, react very differently to corticosteroids.
  • 46. Contraindications to Use Corticosteroids are contraindicated in systemic fungal infections and in people who are hypersensitive to drug formulations. They should be used with caution in clients at risk for infections (they may decrease resistance), clients with infections (they may mask signs and symptoms so that infections become more severe before they are recognized and treated), diabetes mellitus (they cause or increase hyperglycemia), peptic ulcer disease, inflammatory bowel disorders, hypertension, congestive heart failure, and renal insufficiency.
  • 47. Disease-modifying Anti-rheumatic Drugs (DMARDs)  The early use of disease-modifying anti-rheumatic drugs (DMARDs) has been recommended in recent years to reduce disease progression and long-term disability.The need for early use of DMARDs is incorporated in new National Institute for Health and Clinical Excellence (NICE) guidance. Early use requires early referral in part because DMARD initiation is the province of specialists in secondary care. The optimum use of these drugs requires specialist experience and is complicated not only because of their potential toxicity, but also by the range and combination of drugs used. There are a number of new DMARDs.
  • 48. DMARDs  The prevailing guidelines for the management of rheumatoid arthritis (RA) recommend that, once the disease has been diagnosed and its impact on the patient's life documented, DMARDs should be commenced. DMARDs should be part of a range of treatments from different professional disciplines. For further details see separate article Management of Rheumatoid Arthritis.  DMARDs either affect the immune response or suppress the disease process. As well as improving the symptoms and signs of the arthritis, they may also improve the extra-articular manifestations such as vasculitis in addition to exerting systemic effects. Any DMARD that has been prescribed should be recorded in a patient's notes, both written and electronic, so that all doctors prescribing for that patient will be aware of any potential interactions with other drugs.
  • 49. Types of disease-modifying anti- rheumatic drugs DRUGS WHICH SUPPRESS THE DISEASE PROCESS Gold:  May be given either orally as auranofin or by intramuscular injection as sodium aurothiomalate.  Sodium aurothiomalate is licensed for the treatment of rheumatoid arthritis (RA) and juvenile idiopathic arthritis.  Can be an effective treatment but use is restricted by severe adverse reactions (up to 5% of recipients).  Sodium aurothiomalate has a greater toxicity than auranofin, but tends to be more effective and has a faster onset of action.  Either drug should be withdrawn if no benefit is seen after six months.
  • 50. Types of disease-modifying anti-rheumatic drugs DRUGS WHICH SUPPRESS THE DISEASE PROCESS Penicillamine  It is a chelating agent licensed for the treatment of severe active rheumatoid arthritis, including juvenile forms (and a range of other conditions, including Wilson's disease).  It has a similar method of action to gold and more patients are able to tolerate it, but side-effects occur frequently.  The rate of onset of action is slow, improvement may not be seen for three months but, in patients who have shown no benefit after a year of treatment, the drug should be discontinued. Sulfasalazine  It is licensed for the treatment of RA which has failed to respond to non-steroidal anti-inflammatory drugs (NSAIDs).  It has a similar action to gold.  It has slightly more side-effects than methotrexate.
  • 51. Types of disease-modifying anti- rheumatic drugs Drugs which affect the immune process Chloroquine and hydroxychloroquine  Hydroxychloroquine is an antimalarial agent licensed for the treatment of RA, juvenile idiopathic arthritis, discoid and systemic lupus erythematosus, and dermatological conditions caused, or aggravated, by sunlight.  They are usually better tolerated than gold or penicillamine. Methotrexate  May be used in the treatment of RA and psoriatic arthritis.  It is a disease-modifying agent with both anti-inflammatory and immunosuppressant activity.  It is also classified as an antimetabolite cytotoxic agent, and is the most common first-line agent for the early treatment of RA in the UK.
  • 52. Types of disease-modifying anti- rheumatic drugs Drugs which affect the immune process Azathioprine  It is a cytotoxic drug and a prodrug of mercaptopurine.  It is used as an immunosuppressant for many autoimmune conditions and to suppress transplant rejection.  It acts in a similar manner to methotrexate but is usually reserved as second- line due to its toxicity. Ciclosporin  It is a powerful immunosuppressant that appears to act specifically on lymphocytes (mainly helper T cells) resulting in depression of the cell- mediated immune response.  Unlike cytotoxic immunosuppressants (such as cyclophosphamide) it has little effect on bone marrow.  It is licensed for the treatment of severe active rheumatoid arthritis when the usual second-line therapy is inappropriate or ineffective. Leflunomide  Leflunomide has antiproliferative properties.  It is licensed for the treatment of adults with active RA and also for active psoriatic arthritis.  It is used in the treatment of moderate-to-severe, active RA, often in combination with methotrexate.
  • 53. Antitumour necrosis factor or biological agents The term biological agents encompasses tumour necrosis factor (TNF)-alpha blockers (infliximab, etanercept, and adalimumab) and other agents, including abatacept, anakinra, and rituximab.
  • 54. Choosing the right DMARD Current evidence suggests that combinations of DMARDs are more effective, and probably less toxic, than monotherapy.Methotrexate is often used as an anchor drug, combined with hydroxychloroquine, sulfasalazine or leflunomide. An anti-TNF-alpha drug such as etanercept or infliximab may also be used in combination. There is a stronger evidence base for the disease-modifying effects of methotrexate, sulfasalazine, leflunomide and intramuscular gold than for hydroxychloroquine, penicillamine, oral gold, ciclosporin or azathioprine, although these agents do improve symptoms and some objective measures of inflammation. The choice of first agent or combination of agents should be based on a risk/benefit analysis for individual patients.
  • 55. Monitoring The use of disease-modifying anti-rheumatic drugs (DMARDs) is limited by potentially serious side-effects, and therefore patients who are taking these drugs should be monitored on a regular basis as in the table below. Note throughout that, whilst absolute values are useful indicators, trends are also important. Hence any rapid fall or consistent downward trend in any parameter warrants extra vigilance.